<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C4C94958-93C0-42D3-9370-4F43D57329E4"><gtr:id>C4C94958-93C0-42D3-9370-4F43D57329E4</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Schwabe</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105184335"><gtr:id>48C7E488-51E7-4FCD-8E23-19039EAA8C30</gtr:id><gtr:title>Gene regulation by nuclear hormone receptors</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105184335</gtr:grantReference><gtr:abstractText>Large complex organisms require sophisticated communication between distant tissues and organs. Nuclear receptors provide one of the mechanisms through which an individual cell can sense signals coming from outside the cell. Nuclear receptors receive signals in the form of fat-soluble hormones (such as oestrogen) and other signalling molecules (such as vitamin D), which are able to freely enter the cell. In response to binding a signalling molecule, the nuclear receptor then changes which genes are actively expressed (switched on) in that cell. An important part of this mechanism is that many nuclear receptors actively maintain their target genes in an inactive state prior to receiving an activation signal. This is termed transcriptional repression and is clearly a very important and fundamental process. Defects in this repression mechanism in humans are associated with leukaemias and metabolic disease. ||We are seeking to understand the mechanisms through which repression is achieved by studying the molecular structure and function of a large complex of proteins that binds to nuclear receptors in the absence of their activating signals.</gtr:abstractText><gtr:technicalSummary>Nuclear receptors are a biologically and medically important family of transcription factors. In the absence of their activating ligands many nuclear receptors repress basal transcription. This is achieved through the recruitment of a large (1-2MDa) repression complex. Failures in this repression mechanism are associated with a number of human leukaemias and metabolic disease. We are seeking to understand the structure and function of this nuclear receptor repression complex. To date we have gained an understanding of the mechanism through which the repression complex is recruited to nuclear receptors in the absence of ligand and displaced upon ligand activation. We have also solved the structure of a number of the components of the repression complex and mapped their interaction surfaces with other factors. In the future we will continue our structural and functional studies of various components and sub-complexes of the repression complex using proteins expressed in bacteria. However we are particularly interested in obtaining a more complete view of the repression complex as a whole. Our experience suggests that this is unlikely to be possible using bacterial expression. We have therefore initiated a program to express the repression complex on a large-scale in mammalian cells grown in suspension. ||We have recently shown that we can obtain excellent yields of proteins expressed through transient transfection of human embryonic kidney 293F cells. This approach will have the advantage of overcoming the difficulties of expressing large eukaryotic proteins in bacteria. We will use complexes prepared in this way for structural studies using electron microscopy and X-ray crystallography. We will also exploit this system to identify by mass spectroscopy as yet unknown components of the repression complex. ||It is hoped that these studies will extend our understanding of the mechanisms of transcriptional repression by nuclear receptors.||Nuclear receptor, transcription, repression, protein structure, protein complex, regulation, NMR spectroscopy, X-ray crystallography, electron microscopy, protein expression.</gtr:technicalSummary><gtr:fund><gtr:end>2006-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1997-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>213887</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>961D6865-E434-477B-9AC3-5D5C5BBBF6FE</gtr:id><gtr:title>Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains.</gtr:title><gtr:parentPublicationTitle>Journal of molecular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a6d7f5691a28b1d56811336b225f967"><gtr:id>0a6d7f5691a28b1d56811336b225f967</gtr:id><gtr:otherNames>J??skel?inen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0952-5041</gtr:issn><gtr:outcomeId>ZRA2yLNB1QJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A185867-55E4-4914-8F15-F0F49328CECF</gtr:id><gtr:title>Structural basis for the activation of PPARgamma by oxidized fatty acids.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0f579a5fc6fd2d028f720873a1dc58c"><gtr:id>e0f579a5fc6fd2d028f720873a1dc58c</gtr:id><gtr:otherNames>Itoh T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>622479DD_9622479DD_9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>055380A3-0CF0-4F68-85F7-57A3148C2A4E</gtr:id><gtr:title>Structural basis for the assembly of the SMRT/NCoR core transcriptional repression machinery.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43b39ad81fde75917d26c09f25e56927"><gtr:id>43b39ad81fde75917d26c09f25e56927</gtr:id><gtr:otherNames>Oberoi J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>pm_12608_28_21240272</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105184335</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>